0,786  0,005  Sensitization
0,737  0,025  Apoptosis agonist
0,710  0,029  Antiinflammatory
0,687  0,025  Caspase 9 stimulant
0,652  0,008  Cardiovascular analeptic
0,624  0,010  Immunosuppressant
0,614  0,006  UGT1A4 substrate
0,592  0,018  Respiratory analeptic
0,551  0,004  Acaricide
0,548  0,020  5 Hydroxytryptamine release stimulant
0,529  0,015  FMO1 substrate
0,525  0,014  Nitric oxide antagonist
0,518  0,019  Antineoplastic (pancreatic cancer)
0,537  0,039  Transcription factor NF kappa B inhibitor
0,505  0,009  Transplant rejection treatment
0,525  0,048  Antineoplastic (breast cancer)
0,493  0,023  Analeptic
0,486  0,018  Antiprotozoal (Leishmania)
0,481  0,015  ICAM1 expression inhibitor
0,476  0,012  Antineoplastic (liver cancer)
0,493  0,029  CYP2C19 substrate
0,485  0,040  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,450  0,006  Antialcoholic
0,475  0,044  Antileukemic
0,449  0,019  Antiparasitic
0,476  0,057  Alzheimer's disease treatment
0,423  0,008  Antiviral (Influenza)
0,432  0,018  Psychostimulant
0,421  0,009  Cholinergic
0,470  0,058  Analgesic
0,416  0,013  Contraceptive
0,408  0,008  Protein kinase stimulant
0,416  0,017  Antiulcerative
0,402  0,003  Cannabinoid CB2 receptor antagonist
0,427  0,032  Antiosteoporotic
0,400  0,011  Antiacne
0,392  0,007  Antiviral (Influenza A)
0,420  0,036  Antipsoriatic
0,413  0,030  NOS2 expression inhibitor
0,411  0,028  UGT2B4 substrate
0,416  0,035  Antineoplastic (brain cancer)
0,441  0,064  TNF expression inhibitor
0,391  0,017  Antihelmintic
0,427  0,054  CYP2C9 substrate
0,392  0,023  Vascular (periferal) disease treatment
0,406  0,048  Bone diseases treatment
0,401  0,045  Antifungal
0,393  0,038  CTGF expression inhibitor
0,415  0,060  Antipruritic, allergic
0,395  0,041  Spasmolytic
0,364  0,013  Prostate disorders treatment
0,373  0,027  Angiogenesis stimulant
0,388  0,047  Multiple sclerosis treatment
0,346  0,004  Cannabinoid receptor antagonist
0,402  0,062  CYP3A4 substrate
0,397  0,060  Ulceration
0,347  0,012  UGT2B15 substrate
0,356  0,023  Antiparkinsonian, rigidity relieving
0,364  0,036  Antipyretic
0,369  0,041  Antioxidant
0,344  0,018  UGT2B7 substrate
0,358  0,033  Chemopreventive
0,368  0,047  Radioprotector
0,345  0,025  GST M1-1 substrate
0,354  0,035  FMO3 substrate
0,328  0,010  Acetylcholinesterase inhibitor
0,333  0,018  Prostatic (benign) hyperplasia treatment
0,376  0,063  Vasodilator, peripheral
0,317  0,005  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,318  0,007  Neurotrophic factor
0,384  0,073  GST A substrate
0,368  0,058  Cholesterol antagonist
0,314  0,009  Antifungal enhancer
0,375  0,073  GABA C receptor rho-3 antagonist
0,312  0,011  Toxic, respiratory center
0,348  0,047  Interleukin 2 agonist
0,360  0,061  Antithrombotic
0,333  0,038  Flavin-containing monooxygenase substrate
0,330  0,035  Interleukin agonist
0,382  0,090  5 Hydroxytryptamine release inhibitor
0,321  0,031  Abortion inducer
0,324  0,034  5 Hydroxytryptamine uptake stimulant
0,300  0,011  DNA polymerase I inhibitor
0,354  0,064  Prostate cancer treatment
0,344  0,056  NOS3 expression inhibitor
0,289  0,004  Actinic keratosis treatment
0,338  0,056  Antiepileptic
0,341  0,060  Antineoplastic (ovarian cancer)
0,339  0,058  Calcium channel activator
0,364  0,083  CYP2C19 inhibitor
0,306  0,028  P-glycoprotein inhibitor
0,305  0,028  Antihypotensive
0,303  0,029  Hepatoprotectant
0,305  0,031  UGT1A1 substrate
0,281  0,008  Retinoprotector
0,292  0,021  Hair growth stimulant
0,293  0,024  Skin irritative effect
0,303  0,034  UDP-glucuronosyltransferase substrate
0,294  0,025  Pneumotoxic
0,287  0,022  Interferon gamma antagonist
0,325  0,062  Antineoplastic (melanoma)
0,270  0,007  Contraceptive female
0,315  0,053  Chemoprotective
0,266  0,005  Cannabinoid receptor agonist
0,282  0,023  Protein-tyrosine phosphatase inhibitor
0,273  0,015  UGT2B9 substrate
0,313  0,056  Antineurogenic pain
0,294  0,037  Gastrin inhibitor
0,311  0,059  Teratogen
0,263  0,014  Protein-tyrosine phosphatase 1B inhibitor
0,260  0,011  ATPase inhibitor
0,302  0,053  Amyotrophic lateral sclerosis treatment
0,252  0,005  Cannabinoid CB2 receptor agonist
0,251  0,004  Cannabinoid CB1 receptor antagonist
0,253  0,011  Farnesoid X receptor antagonist
0,342  0,107  Antibacterial
0,300  0,066  Antineoplastic (multiple myeloma)
0,309  0,077  Hepatic disorders treatment
0,254  0,028  Anesthetic
0,284  0,063  Embryotoxic
0,304  0,083  Apoptosis antagonist
0,256  0,035  Neurotrophic factor enhancer
0,248  0,028  Carcinogenic, group 3
0,235  0,018  UGT2B10 substrate
0,277  0,061  Proliferative diseases treatment
0,285  0,070  Antihypoxic
0,218  0,005  Cannabinoid CB1 receptor agonist
0,226  0,014  Microtubule formation inhibitor
0,216  0,008  TRPA1 agonist
0,256  0,047  Sedative
0,242  0,038  Antipruritic, non-allergic
0,234  0,031  Melanin inhibitor
0,217  0,015  Antifungal (Cryptococcus)
0,226  0,025  Anesthetic local
0,271  0,072  UGT1A9 substrate
0,248  0,051  RNA-directed DNA polymerase inhibitor
0,204  0,008  Postmenopausal disorders treatment
0,215  0,024  Antirickettsial
0,210  0,020  Ferrochelatase inhibitor
0,254  0,064  Tyrosine 3 hydroxylase inhibitor
0,250  0,061  UGT1A6 substrate
0,211  0,023  Arachidonic acid antagonist
0,240  0,053  VCAM1 expression inhibitor
0,201  0,014  Androgen antagonist
0,244  0,057  Antineoplastic enhancer
0,235  0,049  Non-steroidal antiinflammatory agent
0,251  0,066  DNA synthesis inhibitor
0,289  0,104  Antineoplastic (lung cancer)
0,228  0,046  Diabetic retinopathy treatment
0,212  0,031  Alpha-N-acetylglucosaminidase inhibitor
0,202  0,021  Antismoking
0,253  0,073  Tumour necrosis factor alpha release inhibitor
0,275  0,097  Immunomodulator
0,205  0,028  SULT1A3 substrate
0,256  0,080  Aldehyde oxidase inhibitor
0,232  0,059  Carcinogenic
0,241  0,071  Cytostatic
0,249  0,079  Antihypercholesterolemic
0,244  0,075  Platelet antagonist
0,177  0,008  Anabolic
0,260  0,091  CYP1A2 substrate
0,177  0,008  Ca2+-transporting ATPase inhibitor
0,171  0,004  Sphingosine 1-phosphate receptor 3 agonist
0,216  0,049  Growth factor agonist
0,215  0,049  Antimutagenic
0,169  0,003  CXC chemokine 3 receptor antagonist
0,208  0,043  Succinate dehydrogenase inhibitor
0,194  0,028  Cholesterol synthesis inhibitor
0,186  0,021  Adenylate cyclase stimulant
0,231  0,067  Cytotoxic
0,181  0,017  GABA C receptor antagonist
0,186  0,024  Endometrios treatment
0,209  0,048  5 Hydroxytryptamine 3E antagonist
0,235  0,076  Antiglaucomic
0,169  0,011  GST T1-1 substrate
0,182  0,024  GABA C receptor agonist
0,261  0,103  Caspase 3 stimulant
0,206  0,049  Eye irritation, high
0,161  0,005  Glycine receptor agonist
0,255  0,103  CYP2D6 substrate
0,285  0,135  Antiprotozoal
0,228  0,085  Antineoplastic (glioma)
0,157  0,014  Inducible nitric-oxide synthase inhibitor
0,279  0,136  Histamine release inhibitor
0,204  0,064  CYP2B6 inhibitor
0,147  0,008  ATPase (Vacuolar H+) inhibitor
0,165  0,026  Choleretic
0,205  0,066  Mutagenic
0,197  0,058  Lipocortins synthesis antagonist
0,151  0,014  Antidote, mercury
0,186  0,050  Phobic disorders treatment
0,164  0,029  SULT1A1 substrate
0,148  0,013  Aromatase inhibitor
0,242  0,108  Hypoxia-inducible factor 1 alpha inhibitor
0,148  0,016  UGT2B11 substrate
0,257  0,127  Vasodilator, coronary
0,159  0,030  Vanilloid 1 agonist
0,131  0,005  Sphingosine 1-phosphate receptor 5 agonist
0,139  0,015  Ornithine decarboxylase inhibitor
0,176  0,052  Antiparkinsonian, tremor relieving
0,190  0,067  Antiviral (Hepatitis)
0,243  0,122  AR expression inhibitor
0,150  0,030  HDL-cholesterol increasing
0,157  0,041  Antitussive
0,171  0,056  Carcinogenic, group 1
0,141  0,025  Carcinogenic, group 2A
0,194  0,079  Insulin sensitizer
0,209  0,095  Antineoplastic (cervical cancer)
0,147  0,038  Excitatory amino acid transporter EAAC1 inhibitor
0,123  0,014  Na+ K+ transporting ATPase inhibitor
0,137  0,028  Prolactin inhibitor
0,123  0,016  Glycine receptor antagonist
0,153  0,047  Antihyperlipoproteinemic
0,229  0,123  CYP2D6 inhibitor
0,144  0,039  Antiviral (Papilloma)
0,121  0,017  Nicotinic alpha4beta2 receptor antagonist
0,124  0,020  Glutamate release inhibitor
0,193  0,089  Antihypertriglyceridemic
0,113  0,011  Androgen agonist
0,136  0,034  Antineoplastic antibiotic
0,218  0,116  Cardioprotectant
0,132  0,031  Nitric-oxide synthase inhibitor
0,109  0,009  5-Alpha-reductase inhibitor
0,105  0,005  Nicotinic acid receptor 2 agonist
0,140  0,040  Alcohol dehydrogenase substrate
0,168  0,070  Antihelmintic (Nematodes)
0,151  0,053  Antiseptic
0,157  0,059  Hearing loss treatment
0,195  0,098  Nitric-oxide synthase stimulant
0,142  0,046  Beta amyloid protein antagonist
0,101  0,006  Postcoital contraceptive
0,105  0,012  Antidote, organophosphates
0,121  0,029  Lanosterol 14 alpha demethylase inhibitor
0,134  0,043  Photosensitizer
0,111  0,020  GABA aminotransferase inhibitor
0,121  0,031  Tourette's syndrome treatment
0,174  0,085  Wound healing agent
0,097  0,009  Estrogen receptor alpha agonist
0,131  0,044  Expectorant
0,162  0,074  Antiviral (Hepatitis C)
0,108  0,021  CXC chemokine receptor antagonist
0,128  0,041  Antiemetic
0,123  0,037  GABA C receptor rho-1 antagonist
0,145  0,059  Heat shock protein 70 antagonist
0,146  0,061  Pregnane X receptor agonist
0,201  0,116  Superoxide dismutase inhibitor
0,093  0,009  Aldosterone antagonist
0,095  0,011  SULT2A1 substrate
0,202  0,119  Immunostimulant
0,135  0,053  Autism spectrum disorders treatment
0,265  0,183  Antiarthritic
0,125  0,044  Myasthenia Gravis treatment
0,169  0,089  Platelet adhesion inhibitor
0,105  0,025  Interferon agonist
0,180  0,100  Cardiodepressant
0,098  0,019  Vanilloid 4 agonist
0,087  0,008  Anesthetic inhalation
0,111  0,033  Acetylcholine nicotinic antagonist
0,193  0,116  Antineoplastic (renal cancer)
0,101  0,024  Narcotic antagonist
0,084  0,007  Adenylate cyclase 1 inhibitor
0,087  0,010  Nicotinic alpha3beta2 receptor antagonist
0,159  0,084  Muscle relaxant
0,112  0,037  ABCA1 expression enhancer
0,104  0,029  Vanilloid agonist
0,093  0,019  Estrogen agonist
0,087  0,013  Estrogen receptor beta agonist
0,090  0,017  Interferon inducer
0,150  0,077  CF transmembrane conductance regulator agonist
0,094  0,022  Bcl2 antagonist
0,147  0,074  Antianorexic
0,153  0,081  UGT1A3 substrate
0,172  0,101  Antineoplastic (glioblastoma multiforme)
0,119  0,047  Antiprotozoal (Toxoplasma)
0,148  0,077  Raynaud's phenomenon treatment
0,130  0,060  Coagulant
0,159  0,089  Tumour necrosis factor antagonist
0,107  0,037  Antispirochetal
0,103  0,034  Chymotrypsin inhibitor
0,077  0,008  Pregnane X receptor antagonist
0,124  0,055  Antifungal (Pneumocystis)
0,077  0,008  Retinoid X receptor agonist
0,218  0,150  CYP3A4 inhibitor
0,125  0,057  Menstruation disorders treatment
0,100  0,033  3C-Like protease (SARS coronavirus) inhibitor
0,143  0,076  Genotoxic
0,085  0,019  Glutamate (mGluR6) antagonist
0,106  0,040  Antithrombocytopenic
0,111  0,045  Estrogen receptor beta antagonist
0,157  0,092  Phospholipase C inhibitor
0,117  0,053  Acetylcholine release stimulant
0,120  0,056  5 Hydroxytryptamine 3A agonist
0,095  0,031  Estrogen-related receptor beta agonist
0,106  0,042  Potassium channel activator
0,168  0,105  Antimitotic
0,119  0,057  Estrogen antagonist
0,199  0,137  Antidiabetic (type 2)
0,104  0,042  Bile acid receptor antagonist
0,078  0,016  Heme oxygenase stimulant
0,148  0,088  Uterine stimulant
0,068  0,008  Microtubule stabilization
0,094  0,035  Keratolytic
0,116  0,057  Carcinogenic, group 2B
0,225  0,166  Stroke treatment
0,111  0,053  Butyrylcholinesterase inhibitor
0,061  0,005  Tubulin agonist
0,129  0,074  CC chemokine 6 receptor antagonist
0,078  0,023  Transcription factor AP-1 inhibitor
0,064  0,008  Guanylate cyclase inhibitor
0,194  0,138  5 Hydroxytryptamine 1E antagonist
0,065  0,010  Retinoid X alpha receptor agonist
0,107  0,053  UDP-glucose 4-epimerase inhibitor
0,141  0,087  GABA C receptor rho-2 antagonist
0,077  0,024  Antimycoplasmal
0,100  0,048  Triose-phosphate isomerase inhibitor
0,094  0,041  Sodium/hydrogen exchanger 5 inhibitor
0,072  0,020  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,108  0,056  Antihypermotility
0,058  0,007  Retinoid X receptor antagonist
0,099  0,048  NMDA receptor antagonist
0,109  0,059  UGT2B1 substrate
0,107  0,057  Antifungal (Aspergillus)
0,053  0,003  Progesterone receptor B antagonist
0,157  0,107  Anesthetic general
0,123  0,074  Cyclooxygenase 3 inhibitor
0,103  0,054  Electrolyte absorption antagonist
0,057  0,010  Retinoic acid alpha receptor agonist
0,081  0,034  Phospholipase D inhibitor
0,108  0,062  Glutathione S-transferase substrate
0,105  0,059  Adenylate kinase inhibitor
0,212  0,166  Ca(v)3.3 blocker
0,121  0,075  Cathepsin H inhibitor
0,050  0,005  Retinoid X gamma receptor agonist
0,051  0,006  Retinoid X alpha receptor antagonist
0,087  0,043  T cell inhibitor
0,055  0,012  Alpha 1L adrenoreceptor agonist
0,049  0,006  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,055  0,012  GABA uptake inhibitor
0,181  0,138  Antiprotozoal (Trypanosoma)
0,122  0,080  Amylase inhibitor
0,084  0,043  Estrogen receptor alpha antagonist
0,093  0,052  NADH dehydrogenase inhibitor
0,050  0,009  Vanilloid 3 antagonist
0,065  0,024  Thromboxane A2 antagonist
0,108  0,068  Cystathionine beta-synthase inhibitor
0,078  0,038  Sphingosine 1-phosphate receptor 4 agonist
0,101  0,062  Sulfotransferase substrate
0,075  0,035  Glutamate (mGluR7) antagonist
0,051  0,011  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,116  0,077  Antiviral (Influenza B)
0,083  0,045  Porphobilinogen synthase inhibitor
0,227  0,189  Analgesic, non-opioid
0,105  0,067  DOPA decarboxylase inhibitor
0,042  0,005  Nicotinic acid receptor 2 antagonist
0,097  0,059  Antineoplastic, alkylator
0,054  0,017  Progesterone antagonist
0,082  0,045  Antibiotic
0,044  0,007  5-Alpha-reductase 1 inhibitor
0,106  0,069  Mucolytic
0,112  0,075  Antiprotozoal (Babesia)
0,069  0,033  Biliverdin reductase inhibitor
0,041  0,005  Prostacyclin agonist
0,065  0,029  Thromboxane antagonist
0,110  0,074  Proteasome inhibitor
0,050  0,014  Kainate receptor agonist
0,040  0,004  Vanilloid 2 agonist
0,082  0,047  CYP2A6 inhibitor
0,051  0,017  Dopamine D5 agonist
0,084  0,050  CC chemokine 5 receptor agonist
0,042  0,008  5-Alpha-reductase 2 inhibitor
0,048  0,015  Nicotinic acid receptor agonist
0,099  0,067  Antiviral (Poxvirus)
0,059  0,027  Aconitate hydratase inhibitor
0,088  0,057  Tocolytic
0,060  0,029  Nicotinic receptor alpha7 subunit antagonist
0,037  0,006  Retinoid X beta receptor agonist
0,034  0,004  NMDA receptor phencyclidine site antagonist
0,118  0,088  Skin whitener
0,035  0,005  Retinoic acid gamma receptor agonist
0,073  0,043  Neuronal nicotinic receptor antagonist
0,044  0,015  RNA-directed RNA polymerase stimulant
0,159  0,129  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,069  0,040  Hyperparathyroidism treatment
0,058  0,029  Chemokine receptor agonist
0,069  0,041  Antihemophilic
0,061  0,034  Lipocortins synthesis agonist
0,108  0,080  Mental retardation treatment
0,101  0,073  Antihelmintic (Fasciola)
0,135  0,108  Movement disorders treatment
0,095  0,067  Antifungal (Candida)
0,075  0,048  Epoxide hydrolase inhibitor
0,050  0,023  Geranyltranstransferase inhibitor
0,044  0,018  Potassium channel Kv1.1 blocker
0,046  0,020  Alpha 1d adrenoreceptor agonist
0,113  0,087  Sphingosine 1-phosphate receptor 4 antagonist
0,065  0,040  Calcium channel P-type blocker
0,034  0,008  Retinoid X gamma receptor antagonist
0,054  0,029  Potassium channel (Inward rectifier) activator
0,108  0,084  Transcription factor STAT6 inhibitor
0,037  0,013  Nicotinic alpha3beta4 receptor agonist
0,029  0,005  Retinoid X beta receptor antagonist
0,071  0,047  Phosphofructokinase-1 inhibitor
0,162  0,138  VEGF expression inhibitor
0,032  0,009  Retinoic acid receptor agonist
0,051  0,028  Glucose-6-phosphate isomerase inhibitor
0,052  0,028  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,052  0,028  Mineralocorticoid receptor antagonist
0,032  0,009  Hedgehog signaling activator
0,070  0,047  Anticholelithogenic
0,121  0,098  Cell wall synthesis inhibitor
0,028  0,006  Retinoic acid beta receptor agonist
0,044  0,022  Membrane dipeptidase inhibitor
0,053  0,032  Prolyl endopeptidase inhibitor
0,091  0,070  Creatine kinase inhibitor
0,050  0,029  Potassium channel (ATP-sensitive) activator
0,073  0,052  NAT1 substrate
0,066  0,045  Uterine relaxant
0,084  0,063  Antileprosy
0,110  0,090  CNS active muscle relaxant
0,071  0,051  Aminopeptidase I inhibitor
0,060  0,041  Potassium channel intermediate-conductance Ca-activated blocker
0,024  0,005  Telomerase stimulant
0,072  0,053  CDC25A inhibitor
0,103  0,084  Neutropenia treatment
0,215  0,197  Antineoplastic (endocrine cancer)
0,033  0,015  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,218  0,201  CYP2C9 inhibitor
0,087  0,069  Restless leg syndrome treatment
0,055  0,037  Acyl-CoA dehydrogenase inhibitor
0,084  0,067  GST P1-1 substrate
0,040  0,023  Glutamate (mGluR8) agonist
0,053  0,037  Alpha-mannosidase inhibitor
0,043  0,027  Sphingosine 1-phosphate receptor 1 agonist
0,095  0,079  Beta glucuronidase inhibitor
0,117  0,102  Antiischemic, cerebral
0,113  0,098  Antineoplastic (squamous cell carcinoma)
0,054  0,040  Dihydroorotate oxidase inhibitor
0,087  0,073  Antiviral (Rhinovirus)
0,036  0,022  CXC chemokine receptor agonist
0,060  0,046  Corticotropin releasing factor 2 receptor antagonist
0,051  0,038  Protein 50S ribosomal subunit inhibitor
0,082  0,069  Granulocyte macrophage colony stimulating factor agonist
0,017  0,004  Progesterone receptor A antagonist
0,155  0,143  Cyclic AMP phosphodiesterase inhibitor
0,063  0,051  Acetylcholine M5 receptor agonist
0,045  0,033  Parathyroid hormone antagonist
0,080  0,069  Transcription factor NF kappa B stimulant
0,033  0,021  Glutamate (mGluR3) agonist
0,043  0,032  Nicotinic receptor alpha3 subunit antagonist
0,052  0,041  Acetylcholine muscarinic agonist
0,178  0,167  Antiviral (West Nile virus)
0,031  0,020  Acetylcholine M4 receptor agonist
0,021  0,010  Progesterone agonist
0,018  0,008  Vitamin D receptor agonist
0,020  0,011  Retinoic acid receptor antagonist
0,060  0,051  CDC25B inhibitor
0,047  0,038  HCV NS3/NS4A protease inhibitor
0,055  0,046  Calcium channel T-type blocker
0,023  0,015  GRP78 expression inhibitor
0,138  0,130  LDLR expression enhancer
0,058  0,050  NMDA receptor agonist
0,068  0,060  Glutamate dehydrogenase inhibitor
0,046  0,039  Cytokine production stimulant
0,020  0,014  Retinoic acid alpha receptor antagonist
0,126  0,119  Pulmonary hypertension treatment
0,016  0,010  Thromboxane A2 agonist
0,036  0,030  Glucose-6-phosphate dehydrogenase inhibitor
0,034  0,027  Adenosine uptake inhibitor
0,011  0,005  CXC chemokine 3 receptor agonist
0,077  0,071  Sleep apnea treatment
0,039  0,033  Acetylcholine M1 receptor agonist
0,037  0,032  5 Hydroxytryptamine 2B agonist
0,041  0,036  Sphingosine 1-phosphate receptor agonist
0,055  0,050  Sphingosine kinase inhibitor
0,035  0,030  Delayed rectifier potassium channel blocker
0,030  0,025  ATP citrate lysase inhibitor
0,044  0,040  Cholesterol esterase inhibitor
0,149  0,146  Free radical scavenger
0,114  0,110  Antieczematic
0,020  0,017  Estrone sulfatase inhibitor
0,054  0,050  Carbamoyl phosphate synthetase inhibitor
0,041  0,038  Heme oxygenase inhibitor
0,176  0,174  Transcription factor STAT inhibitor
0,025  0,023  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,185  0,182  Insulysin inhibitor
0,075  0,073  Acetylcholine agonist
0,021  0,019  Prostaglandin F2 alpha agonist
0,122  0,120  Sphingosine 1-phosphate receptor 5 antagonist
0,204  0,203  Antiobesity
0,141  0,140  Anticonvulsant
0,010  0,009  Thromboxane agonist
0,068  0,067  SULT1A2 substrate
0,049  0,049  Argininosuccinate synthase inhibitor
0,174  0,174  Transcription factor STAT3 inhibitor
0,063  0,063  MDM2 inhibitor

